Sei Investments Co. Raises Stake in Astrana Health, Inc. $ASTH

Key Points

• Institutional ownership increased: Sei Investments raised its Astrana Health stake by 94.4% to 134,899 shares, while institutional investors collectively own 52.77% of the company.
• Analyst sentiment remains positive: Seven analysts rate ASTH a Buy and two rate it Hold, producing a consensus “Moderate Buy” rating and an average price target of $48.29.
• Growth remains strong but margins are thin: The company’s latest reported quarterly revenue rose 55.6% year over year to $965.1 million, while EPS significantly exceeded estimates. Analysts expect $1.18 in full-year EPS, although the company’s net margin was just 1.05%.

Sei Investments Co. grew its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 94.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,899 shares of the company's stock after purchasing an additional 65,509 shares during the period. Sei Investments Co. owned approximately 0.24% of Astrana Health worth $3,308,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of ASTH. Hussman Strategic Advisors Inc. increased its holdings in shares of Astrana Health by 200.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 63,000 shares of the company's stock worth $1,563,000 after buying an additional 42,000 shares during the period. UBS Group AG lifted its stake in shares of Astrana Health by 48.4% in the 4th quarter. UBS Group AG now owns 176,100 shares of the company's stock valued at $4,369,000 after acquiring an additional 57,432 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Astrana Health by 15.7% during the 1st quarter. Principal Financial Group Inc. now owns 265,948 shares of the company's stock valued at $6,521,000 after acquiring an additional 36,150 shares during the period. Louisiana State Employees Retirement System purchased a new stake in Astrana Health during the 1st quarter valued at about $468,000. Finally, Diamond Hill Capital Management Inc. grew its position in Astrana Health by 19.8% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 432,726 shares of the company's stock worth $10,736,000 after acquiring an additional 71,462 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on ASTH. TD Cowen boosted their price objective on Astrana Health from $45.00 to $50.00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. Truist Financial lifted their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a "buy" rating in a research report on Thursday, May 14th. Wall Street Zen upgraded Astrana Health from a "hold" rating to a "buy" rating in a report on Saturday. Needham & Company LLC raised their price target on Astrana Health from $30.00 to $41.00 and gave the stock a "buy" rating in a research note on Friday, May 8th. Finally, Barclays lifted their price target on shares of Astrana Health from $50.00 to $53.00 and gave the company an "overweight" rating in a report on Friday. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $48.29.

Astrana Health Trading Up 4.8%

Shares of NASDAQ:ASTH opened at $35.76 on Friday. The company has a market cap of $1.99 billion, a P/E ratio of 43.61 and a beta of 0.87. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. Astrana Health, Inc. has a 1 year low of $18.08 and a 1 year high of $51.60. The stock's fifty day moving average price is $41.36 and its 200-day moving average price is $32.47.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.29 by $0.45. Astrana Health had a return on equity of 10.43% and a net margin of 1.05%.The company had revenue of $965.10 million during the quarter, compared to the consensus estimate of $949.21 million. During the same period last year, the company earned $0.42 EPS. Astrana Health's revenue for the quarter was up 55.6% on a year-over-year basis. Sell-side analysts expect that Astrana Health, Inc. will post 1.18 earnings per share for the current year.

Astrana Health News Summary

Here are the key news stories impacting Astrana Health this week:

• Positive Sentiment: Adjusted earnings exceeded expectations. Astrana Health reported non-GAAP earnings of $0.40 per share, up from $0.19 a year earlier and above the $0.31 consensus estimate. A separate report cited $0.80 in EPS versus a $0.34 estimate, reflecting differences between reported and adjusted measures. ASTH Q2 Earnings Top Estimates
• Positive Sentiment: Revenue continued to grow rapidly. Second-quarter revenue reached approximately $972.5 million, an increase of 48.5% year over year. Management and analysts highlighted operating leverage, technology investments and artificial intelligence initiatives as potential drivers of future profitability. ASTH Q2 Deep Dive
• Positive Sentiment: Third-quarter revenue guidance points to continued expansion. Astrana Health forecast revenue of $1.00 billion to $1.03 billion for the third quarter, supporting expectations for sustained growth. ASTH Third-Quarter Revenue Guidance
• Neutral Sentiment: Full-year revenue guidance was maintained at $3.8 billion to $4.1 billion. The midpoint is broadly consistent with the roughly $4.0 billion analyst consensus, suggesting no major change to the outlook. Astrana Health Second-Quarter Results
• Negative Sentiment: Quarterly revenue was below expectations. Revenue of approximately $972.5 million trailed the $985.6 million consensus estimate. Astrana Health also continues to operate with a thin net margin, making execution and cost control important to the stock’s valuation. Astrana Health Earnings Report

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source